The Cancer Letter

Inside information on cancer research and drug development

In Brief

Christopher Manley and Kristen Scully Manley join Fox Chase

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

CHRISTOPHER MANLEY and KRISTEN SCULLY MANLEY joined Fox Chase Cancer Center.

Christopher Manley will serve as the director of interventional pulmonology in the Department of Medicine, and Kristen Scully Manley will serve as a hospitalist in the department of medicine.

“Dr. Manley’s expertise in pulmonary medicine makes him the perfect candidate for our new director of interventional pulmonology,” said David Weinberg, chair of the department of medicine.

He will join Fox Chase after finishing his interventional pulmonology fellowship at Beth Israel Deaconess Medical Center and Massachusetts General Hospital this summer.

Scully Manley most recently served as a member of the hospitalist team in the division of general medicine and primary care at Beth Israel Deaconess, where she was honored as Clinician of the Year in 2015.

Table of Contents

YOU MAY BE INTERESTED IN

Regulatory News

New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctors
Problem: “Breast density is in the eye of the mammographer”

Collage art of mammograms of dense breastsIllustrator: Cyrus FineganWhile breast cancer experts are anything but clear on what the words “dense breasts” signify in the clinic, or for that matter, in the English language, FDA appears to be less perplexed. 
By Claire Marie Porter
Table of Contents

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account